Who are Bionova Pharmaceuticals's investors?

Bionova Pharmaceuticals's investors include Servier Ventures.

When was Bionova Pharmaceuticals founded?

Bionova Pharmaceuticals was founded in 2018.

Where is Bionova Pharmaceuticals headquartered?

Bionova Pharmaceuticals is headquartered in Shanghai, China.

What industry is Bionova Pharmaceuticals in?

Bionova Pharmaceuticals operates in Oncology.

How many employees does Bionova Pharmaceuticals have?

Bionova Pharmaceuticals has 1-10 employees.

Bionova Pharmaceuticals

Acquired

Shanghai, China · Founded 2018

Oncology

Headquarters: Shanghai
Employees: 1–10
Founded: 2018

Business Model: B2B
Website: bionovapharma.com
Acquisition Date: May 2025

About

BioNova Pharmaceuticals (Shanghai) Limited is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of innovative medicines for cancer and other life-threatening diseases with high unmet medical needs. The company builds its pipeline through internal R&D programs as well as collaborations with and acquisitions from partners with cutting-edge technology, including small molecule inhibitors and targeted therapeutics such as BN101 (graft-versus-host disease), BN102 (BTK inhibitor), and BN103/BN104 targeting hematologic malignancies. Founded in 2018 and headquartered in Shanghai, BioNova operates as a fast-growing organization backed by investors including Mitsui & Co. Global Investment.

Summary

Bionova Pharmaceuticals is an Oncology company based in Shanghai, China, founded in 2018. Investors include Servier Ventures.